Test guide

Circulating Tumor DNA to Total Circulating Cell-Free DNA Ratio Measurement

The determination of the ratio of circulating tumor-derived DNA compared to total circulating cell-free DNA in a sample. The measurement may be expressed as a ratio or percentage.

For professionalsReviewed 2026-11-20

Key takeaways

The determination of the ratio of circulating tumor-derived DNA compared to total circulating cell-free DNA in a sample. The measurement may be expressed as a ratio or percentage.

  • Limitations: Terminology reference for a laboratory procedure. The source definition does not establish routine clinical availability, validated specimen types, reference…
  • Intended audience: Laboratory professionals
  • Last reviewed: 2026-11-21

What it is for

Source: National Cancer Institute, NCI Thesaurus 26.10d, C177519. Unmodified NCI definition, CC BY 4.0. Source identity and classification checked automatically on 2026-11-20.

Limitations

Terminology reference for a laboratory procedure. The source definition does not establish routine clinical availability, validated specimen types, reference intervals, product authorization or suitability for an individual. Consult the performing laboratory for its validated method and interpretation.

Also known as

  • Circulating Tumor DNA to Total Circulating Cell-Free DNA Ratio Measurement
  • Circulating Tumor DNA Tumor Fraction
  • Circulating Tumor DNA Tumor Fraction Measurement
  • Circulating Tumor-Derived DNA to Circulating Cell-Free DNA Ratio Measurement
  • ctdDNA to cfDNA Ratio Measurement
  • ctDNA to cfDNA Ratio Measurement
  • TFx in cfDNA
  • Tumor Fraction in Cell-Free DNA

Reviewed products

Curated product links for this test are still under editorial review. Meanwhile, browse the product directory or request a supplier match below.

Request supplier match for this test

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-11-21

Updated

2026-11-21

Disclaimer

professional use

FAQ

Common questions

What does the Circulating Tumor DNA to Total Circulating Cell-Free DNA Ratio Measurement test measure?

The determination of the ratio of circulating tumor-derived DNA compared to total circulating cell-free DNA in a sample. The measurement may be expressed as a ratio or percentage.

How is the Circulating Tumor DNA to Total Circulating Cell-Free DNA Ratio Measurement test performed?

Detection methods are not published on this record; confirm against the manufacturer’s instructions for use.

What sample types does the Circulating Tumor DNA to Total Circulating Cell-Free DNA Ratio Measurement test use?

Sample types are not published on this record; confirm against the manufacturer’s instructions for use.

What are the limitations of the Circulating Tumor DNA to Total Circulating Cell-Free DNA Ratio Measurement test?

Terminology reference for a laboratory procedure. The source definition does not establish routine clinical availability, validated specimen types, reference intervals, product authorization or suitability for an individual. Consult the…

Explore more